10.24335/L28627
RoyaltyStat
Co-exclusive collaborative program to develop, manufacture and commercialize an anti-TNFalpha compound to treat rheumatoid arthritis and other indications, other than Crohn's disease, for human therapy, with licensor to supply product.
RoyaltyStat
2004